The global Sevoflurane and Desflurane Anaesthetics market was valued at US$ 955 million in 2025 and is anticipated to reach US$ 1228 million by 2032, at a CAGR of 3.7% from 2026 to 2032.

Sevoflurane and Desflurane Anaesthetics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sevoflurane and Desflurane Anaesthetics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Sevoflurane and desflurane are modern volatile inhalational anaesthetics used to maintain general anaesthesia (and, for sevoflurane, commonly to induce anaesthesia by mask, especially in paediatrics) by being vaporised in an anaesthesia machine and inhaled to produce unconsciousness, amnesia, and immobility. Sevoflurane is valued for its relatively pleasant, non-pungent profile that makes it easier to breathe in and smooth for inhalational induction, while desflurane is more pungent and can irritate the airway but has very low blood–gas solubility, allowing particularly rapid changes in anaesthetic depth and typically faster wake-up, which can be useful for shorter cases and quicker emergence. Both can lower blood pressure and depress breathing in a dose-dependent way and require appropriate scavenging to limit occupational exposure; they also differ operationally in that desflurane’s physical properties require a dedicated heated/pressurised vaporiser, whereas sevoflurane uses a conventional agent-specific vaporiser, and sevoflurane undergoes more metabolism than desflurane, which is largely exhaled unchanged. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.

Upstream for Inhalation anesthesia centers on specialty fluorine and fine-chemical supply chains: petrochemical feedstocks are converted into high-purity fluorinated intermediates and then into volatile agents such as sevoflurane, desflurane, and isoflurane (fluorinated ethers), followed by pharmaceutical-grade purification, stability/impurity control, and GMP fill-finish into vaporizer bottles/cylinders with compliant packaging and QA release. The midstream channel is dominated by regulated pharma distribution (manufacturers → national wholesalers/GPOs → hospital pharmacies/OR supply), alongside the anesthesia equipment ecosystem (vaporizers, anesthesia workstations, breathing circuits, and increasingly waste-gas management). Downstream, consumption is primarily in hospitals and ambulatory surgery centers (general anesthesia maintenance and adjunct use), with additional demand from dental sedation services and veterinary anesthesia, and utilization is shaped by clinical protocols (fresh-gas-flow practices, agent selection) and facility infrastructure (central gas systems, scavenging).

The segment is mature and closely tied to surgical volumes, but competitive dynamics are increasingly driven by environmental policy and decarbonization in healthcare, because most inhaled agents are vented largely unchanged and can have high climate impact; professional guidance and research consistently flag desflurane as the most climate-intensive among common volatile agents. As a result, major systems have moved to restrict or decommission desflurane (e.g., NHS England limiting routine use from April 2024) and the EU has rules that prohibit routine desflurane use from 1 January 2026 except when medically justified, pushing formularies toward sevoflurane/isoflurane, lower-flow techniques, and in some cases greater use of TIVA where clinically appropriate. At the same time, suppliers and hospitals are investing in “greener anesthesia” levers—better monitoring and low-flow optimization, selective nitrous oxide infrastructure reduction, and emerging capture/destruction solutions—so differentiation is shifting from “just supply” toward emissions-aware clinical support, compliance documentation, and system-level implementation.

This report delivers a comprehensive overview of the global Sevoflurane and Desflurane Anaesthetics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sevoflurane and Desflurane Anaesthetics. The Sevoflurane and Desflurane Anaesthetics market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sevoflurane and Desflurane Anaesthetics market comprehensively. Regional market sizes by Type, by Application, by MAC, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sevoflurane and Desflurane Anaesthetics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sevoflurane and Desflurane Anaesthetics Market Report

Report Metric	Details
Report Name	Sevoflurane and Desflurane Anaesthetics Market
Accounted market size in 2025	US$ 955 million
Forecasted market size in 2032	US$ 1228 million
CAGR	3.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Sevoflurane Desflurane
Segment by MAC	Below 3% Above 3%
Segment by Airway Tolerability	Less Pungent More Pungent
by Application	Human Use Animal Use
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by MAC, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sevoflurane and Desflurane Anaesthetics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sevoflurane and Desflurane Anaesthetics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Sevoflurane and Desflurane Anaesthetics Market growing?

Ans: The Sevoflurane and Desflurane Anaesthetics Market witnessing a CAGR of 3.7% during the forecast period 2026-2032.

What is the Sevoflurane and Desflurane Anaesthetics Market size in 2032?

Ans: The Sevoflurane and Desflurane Anaesthetics Market size in 2032 will be US$ 1228 million.

Who are the main players in the Sevoflurane and Desflurane Anaesthetics Market report?

Ans: The main players in the Sevoflurane and Desflurane Anaesthetics Market are Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer

What are the Application segmentation covered in the Sevoflurane and Desflurane Anaesthetics Market report?

Ans: The Applications covered in the Sevoflurane and Desflurane Anaesthetics Market report are Human Use, Animal Use

What are the Type segmentation covered in the Sevoflurane and Desflurane Anaesthetics Market report?

Ans: The Types covered in the Sevoflurane and Desflurane Anaesthetics Market report are Sevoflurane, Desflurane

1 Sevoflurane and Desflurane Anaesthetics Market Overview

1.1 Product Definition

1.2 Sevoflurane and Desflurane Anaesthetics by Type

1.2.1 Global Sevoflurane and Desflurane Anaesthetics Market Value by Type: 2025 vs 2032

1.2.2 Sevoflurane

1.2.3 Desflurane

1.3 Sevoflurane and Desflurane Anaesthetics by MAC

1.3.1 Global Sevoflurane and Desflurane Anaesthetics Market Value by MAC: 2025 vs 2032

1.3.2 Below 3%

1.3.3 Above 3%

1.4 Sevoflurane and Desflurane Anaesthetics by Airway Tolerability

1.4.1 Global Sevoflurane and Desflurane Anaesthetics Market Value by Airway Tolerability: 2025 vs 2032

1.4.2 Less Pungent

1.4.3 More Pungent

1.5 Sevoflurane and Desflurane Anaesthetics by Application

1.5.1 Global Sevoflurane and Desflurane Anaesthetics Market Value by Application: 2025 vs 2032

1.5.2 Human Use

1.5.3 Animal Use

1.6 Global Sevoflurane and Desflurane Anaesthetics Market Size Estimates and Forecasts

1.6.1 Global Sevoflurane and Desflurane Anaesthetics Revenue 2021–2032

1.6.2 Global Sevoflurane and Desflurane Anaesthetics Sales 2021–2032

1.6.3 Global Sevoflurane and Desflurane Anaesthetics Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Sevoflurane and Desflurane Anaesthetics Market Competition by Manufacturers

2.1 Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Manufacturers (2021–2026)

2.2 Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Sevoflurane and Desflurane Anaesthetics Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Sevoflurane and Desflurane Anaesthetics, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Sevoflurane and Desflurane Anaesthetics, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Sevoflurane and Desflurane Anaesthetics, Product Types and Applications

2.7 Global Key Manufacturers of Sevoflurane and Desflurane Anaesthetics, Date of Entry into the Industry

2.8 Global Sevoflurane and Desflurane Anaesthetics Market Competitive Situation and Trends

2.8.1 Global Sevoflurane and Desflurane Anaesthetics Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Sevoflurane and Desflurane Anaesthetics Players Market Share by Revenue

2.8.3 Global Sevoflurane and Desflurane Anaesthetics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sevoflurane and Desflurane Anaesthetics Market Scenario by Region

3.1 Global Sevoflurane and Desflurane Anaesthetics Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Sevoflurane and Desflurane Anaesthetics Sales by Region: 2021–2032

3.2.1 Global Sevoflurane and Desflurane Anaesthetics Sales by Region: 2021–2026

3.2.2 Global Sevoflurane and Desflurane Anaesthetics Sales by Region: 2027–2032

3.3 Global Sevoflurane and Desflurane Anaesthetics Revenue by Region: 2021–2032

3.3.1 Global Sevoflurane and Desflurane Anaesthetics Revenue by Region: 2021–2026

3.3.2 Global Sevoflurane and Desflurane Anaesthetics Revenue by Region: 2027–2032

3.4 North America Sevoflurane and Desflurane Anaesthetics Market Facts & Figures by Country

3.4.1 North America Sevoflurane and Desflurane Anaesthetics Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Sevoflurane and Desflurane Anaesthetics Sales by Country (2021–2032)

3.4.3 North America Sevoflurane and Desflurane Anaesthetics Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Sevoflurane and Desflurane Anaesthetics Market Facts & Figures by Country

3.5.1 Europe Sevoflurane and Desflurane Anaesthetics Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Sevoflurane and Desflurane Anaesthetics Sales by Country (2021–2032)

3.5.3 Europe Sevoflurane and Desflurane Anaesthetics Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sevoflurane and Desflurane Anaesthetics Market Facts & Figures by Region

3.6.1 Asia Pacific Sevoflurane and Desflurane Anaesthetics Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Sevoflurane and Desflurane Anaesthetics Sales by Region (2021–2032)

3.6.3 Asia Pacific Sevoflurane and Desflurane Anaesthetics Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Sevoflurane and Desflurane Anaesthetics Market Facts & Figures by Country

3.7.1 Latin America Sevoflurane and Desflurane Anaesthetics Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Sevoflurane and Desflurane Anaesthetics Sales by Country (2021–2032)

3.7.3 Latin America Sevoflurane and Desflurane Anaesthetics Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Sevoflurane and Desflurane Anaesthetics Market Facts & Figures by Country

3.8.1 Middle East and Africa Sevoflurane and Desflurane Anaesthetics Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Sevoflurane and Desflurane Anaesthetics Sales by Country (2021–2032)

3.8.3 Middle East and Africa Sevoflurane and Desflurane Anaesthetics Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Sevoflurane and Desflurane Anaesthetics Sales by Type (2021–2032)

4.1.1 Global Sevoflurane and Desflurane Anaesthetics Sales by Type (2021–2026)

4.1.2 Global Sevoflurane and Desflurane Anaesthetics Sales by Type (2027–2032)

4.1.3 Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Type (2021–2032)

4.2 Global Sevoflurane and Desflurane Anaesthetics Revenue by Type (2021–2032)

4.2.1 Global Sevoflurane and Desflurane Anaesthetics Revenue by Type (2021–2026)

4.2.2 Global Sevoflurane and Desflurane Anaesthetics Revenue by Type (2027–2032)

4.2.3 Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Type (2021–2032)

4.3 Global Sevoflurane and Desflurane Anaesthetics Price by Type (2021–2032)

5 Segment by Application

5.1 Global Sevoflurane and Desflurane Anaesthetics Sales by Application (2021–2032)

5.1.1 Global Sevoflurane and Desflurane Anaesthetics Sales by Application (2021–2026)

5.1.2 Global Sevoflurane and Desflurane Anaesthetics Sales by Application (2027–2032)

5.1.3 Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Application (2021–2032)

5.2 Global Sevoflurane and Desflurane Anaesthetics Revenue by Application (2021–2032)

5.2.1 Global Sevoflurane and Desflurane Anaesthetics Revenue by Application (2021–2026)

5.2.2 Global Sevoflurane and Desflurane Anaesthetics Revenue by Application (2027–2032)

5.2.3 Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Application (2021–2032)

5.3 Global Sevoflurane and Desflurane Anaesthetics Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Company Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Baxter Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 AbbVie

6.2.1 AbbVie Company Information

6.2.2 AbbVie Description and Business Overview

6.2.3 AbbVie Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 AbbVie Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.2.5 AbbVie Recent Developments/Updates

6.3 Piramal Critical Care

6.3.1 Piramal Critical Care Company Information

6.3.2 Piramal Critical Care Description and Business Overview

6.3.3 Piramal Critical Care Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Piramal Critical Care Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.3.5 Piramal Critical Care Recent Developments/Updates

6.4 Fresenius Kabi

6.4.1 Fresenius Kabi Company Information

6.4.2 Fresenius Kabi Description and Business Overview

6.4.3 Fresenius Kabi Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Fresenius Kabi Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.4.5 Fresenius Kabi Recent Developments/Updates

6.5 Halocarbon

6.5.1 Halocarbon Company Information

6.5.2 Halocarbon Description and Business Overview

6.5.3 Halocarbon Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Halocarbon Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.5.5 Halocarbon Recent Developments/Updates

6.6 Aspen

6.6.1 Aspen Company Information

6.6.2 Aspen Description and Business Overview

6.6.3 Aspen Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Aspen Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.6.5 Aspen Recent Developments/Updates

6.7 Pfizer

6.7.1 Pfizer Company Information

6.7.2 Pfizer Description and Business Overview

6.7.3 Pfizer Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Pfizer Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Maruishi Pharmaceutical

6.8.1 Maruishi Pharmaceutical Company Information

6.8.2 Maruishi Pharmaceutical Description and Business Overview

6.8.3 Maruishi Pharmaceutical Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Maruishi Pharmaceutical Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.8.5 Maruishi Pharmaceutical Recent Developments/Updates

6.9 Jiangsu Hengrui Medicine

6.9.1 Jiangsu Hengrui Medicine Company Information

6.9.2 Jiangsu Hengrui Medicine Description and Business Overview

6.9.3 Jiangsu Hengrui Medicine Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Jiangsu Hengrui Medicine Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates

6.10 Lunan Pharmaceutical

6.10.1 Lunan Pharmaceutical Company Information

6.10.2 Lunan Pharmaceutical Description and Business Overview

6.10.3 Lunan Pharmaceutical Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Lunan Pharmaceutical Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.10.5 Lunan Pharmaceutical Recent Developments/Updates

6.11 Hikma Pharmaceuticals

6.11.1 Hikma Pharmaceuticals Company Information

6.11.2 Hikma Pharmaceuticals Description and Business Overview

6.11.3 Hikma Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Hikma Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.11.5 Hikma Pharmaceuticals Recent Developments/Updates

6.12 HeBei YiPin Pharmaceutical

6.12.1 HeBei YiPin Pharmaceutical Company Information

6.12.2 HeBei YiPin Pharmaceutical Description and Business Overview

6.12.3 HeBei YiPin Pharmaceutical Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 HeBei YiPin Pharmaceutical Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.12.5 HeBei YiPin Pharmaceutical Recent Developments/Updates

6.13 Dechra Pharmaceuticals

6.13.1 Dechra Pharmaceuticals Company Information

6.13.2 Dechra Pharmaceuticals Description and Business Overview

6.13.3 Dechra Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Dechra Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.13.5 Dechra Pharmaceuticals Recent Developments/Updates

6.14 Life Sciences

6.14.1 Life Sciences Company Information

6.14.2 Life Sciences Description and Business Overview

6.14.3 Life Sciences Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Life Sciences Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.14.5 Life Sciences Recent Developments/Updates

6.15 Zhejiang AngLiKang Pharmaceutical

6.15.1 Zhejiang AngLiKang Pharmaceutical Company Information

6.15.2 Zhejiang AngLiKang Pharmaceutical Description and Business Overview

6.15.3 Zhejiang AngLiKang Pharmaceutical Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Zhejiang AngLiKang Pharmaceutical Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates

6.16 Linde Healthcare

6.16.1 Linde Healthcare Company Information

6.16.2 Linde Healthcare Description and Business Overview

6.16.3 Linde Healthcare Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Linde Healthcare Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.16.5 Linde Healthcare Recent Developments/Updates

6.17 Air Liquide

6.17.1 Air Liquide Company Information

6.17.2 Air Liquide Description and Business Overview

6.17.3 Air Liquide Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Air Liquide Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.17.5 Air Liquide Recent Developments/Updates

6.18 Messer

6.18.1 Messer Company Information

6.18.2 Messer Description and Business Overview

6.18.3 Messer Sevoflurane and Desflurane Anaesthetics Sales, Revenue, and Gross Margin (2021–2026)

6.18.4 Messer Sevoflurane and Desflurane Anaesthetics Product Portfolio

6.18.5 Messer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sevoflurane and Desflurane Anaesthetics Industry Chain Analysis

7.2 Sevoflurane and Desflurane Anaesthetics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sevoflurane and Desflurane Anaesthetics Production Mode & Process Analysis

7.4 Sevoflurane and Desflurane Anaesthetics Sales and Marketing

7.4.1 Sevoflurane and Desflurane Anaesthetics Sales Channels

7.4.2 Sevoflurane and Desflurane Anaesthetics Distributors

7.5 Sevoflurane and Desflurane Anaesthetics Customer Analysis

8 Sevoflurane and Desflurane Anaesthetics Market Dynamics

8.1 Sevoflurane and Desflurane Anaesthetics Industry Trends

8.2 Sevoflurane and Desflurane Anaesthetics Market Drivers

8.3 Sevoflurane and Desflurane Anaesthetics Market Challenges

8.4 Sevoflurane and Desflurane Anaesthetics Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Baxter

AbbVie

Piramal Critical Care

Maruishi Pharmaceutical

Jiangsu Hengrui Medicine

Lunan Pharmaceutical

Hikma Pharmaceuticals

Hebei Yipin Pharmaceutical

Dechra Pharmaceuticals

Life Sciences

Zhejiang Anglikang Pharmaceutical

Linde Healthcare

Air Liquide

Messer

List of Tables

Table 1. Global Sevoflurane and Desflurane Anaesthetics Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Sevoflurane and Desflurane Anaesthetics Market Value by MAC (US$ Million), 2025 vs 2032

Table 3. Global Sevoflurane and Desflurane Anaesthetics Market Value by Airway Tolerability (US$ Million), 2025 vs 2032

Table 4. Global Sevoflurane and Desflurane Anaesthetics Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Sevoflurane and Desflurane Anaesthetics Market Competitive Situation by Manufacturers in 2025

Table 6. Global Sevoflurane and Desflurane Anaesthetics Sales (Tons) of Key Manufacturers (2021–2026)

Table 7. Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Sevoflurane and Desflurane Anaesthetics Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Sevoflurane and Desflurane Anaesthetics Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Sevoflurane and Desflurane Anaesthetics Average Price (US$/kg) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Sevoflurane and Desflurane Anaesthetics, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Sevoflurane and Desflurane Anaesthetics, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Sevoflurane and Desflurane Anaesthetics, Product Types and Applications

Table 14. Global Key Manufacturers of Sevoflurane and Desflurane Anaesthetics, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Sevoflurane and Desflurane Anaesthetics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sevoflurane and Desflurane Anaesthetics Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Sevoflurane and Desflurane Anaesthetics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Sevoflurane and Desflurane Anaesthetics Sales by Region (Tons), 2021–2026

Table 20. Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Region (2021–2026)

Table 21. Global Sevoflurane and Desflurane Anaesthetics Sales by Region (Tons), 2027–2032

Table 22. Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Region (2027–2032)

Table 23. Global Sevoflurane and Desflurane Anaesthetics Revenue by Region (US$ Million), 2021–2026

Table 24. Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Region (2021–2026)

Table 25. Global Sevoflurane and Desflurane Anaesthetics Revenue by Region (US$ Million), 2027–2032

Table 26. Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Region (2027–2032)

Table 27. North America Sevoflurane and Desflurane Anaesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Sevoflurane and Desflurane Anaesthetics Sales by Country (Tons), 2021–2026

Table 29. North America Sevoflurane and Desflurane Anaesthetics Sales by Country (Tons), 2027–2032

Table 30. North America Sevoflurane and Desflurane Anaesthetics Revenue by Country (US$ Million), 2021–2026

Table 31. North America Sevoflurane and Desflurane Anaesthetics Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Sevoflurane and Desflurane Anaesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Sevoflurane and Desflurane Anaesthetics Sales by Country (Tons), 2021–2026

Table 34. Europe Sevoflurane and Desflurane Anaesthetics Sales by Country (Tons), 2027–2032

Table 35. Europe Sevoflurane and Desflurane Anaesthetics Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Sevoflurane and Desflurane Anaesthetics Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Sevoflurane and Desflurane Anaesthetics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Sevoflurane and Desflurane Anaesthetics Sales by Region (Tons), 2021–2026

Table 39. Asia Pacific Sevoflurane and Desflurane Anaesthetics Sales by Region (Tons), 2027–2032

Table 40. Asia Pacific Sevoflurane and Desflurane Anaesthetics Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Sevoflurane and Desflurane Anaesthetics Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Sevoflurane and Desflurane Anaesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Sevoflurane and Desflurane Anaesthetics Sales by Country (Tons), 2021–2026

Table 44. Latin America Sevoflurane and Desflurane Anaesthetics Sales by Country (Tons), 2027–2032

Table 45. Latin America Sevoflurane and Desflurane Anaesthetics Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Sevoflurane and Desflurane Anaesthetics Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Sevoflurane and Desflurane Anaesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Sevoflurane and Desflurane Anaesthetics Sales by Country (Tons), 2021–2026

Table 49. Middle East and Africa Sevoflurane and Desflurane Anaesthetics Sales by Country (Tons), 2027–2032

Table 50. Middle East and Africa Sevoflurane and Desflurane Anaesthetics Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Sevoflurane and Desflurane Anaesthetics Revenue by Country (US$ Million), 2027–2032

Table 52. Global Sevoflurane and Desflurane Anaesthetics Sales (Tons) by Type (2021–2026)

Table 53. Global Sevoflurane and Desflurane Anaesthetics Sales (Tons) by Type (2027–2032)

Table 54. Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Type (2021–2026)

Table 55. Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Type (2027–2032)

Table 56. Global Sevoflurane and Desflurane Anaesthetics Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Sevoflurane and Desflurane Anaesthetics Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Type (2021–2026)

Table 59. Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Type (2027–2032)

Table 60. Global Sevoflurane and Desflurane Anaesthetics Price (US$/kg) by Type (2021–2026)

Table 61. Global Sevoflurane and Desflurane Anaesthetics Price (US$/kg) by Type (2027–2032)

Table 62. Global Sevoflurane and Desflurane Anaesthetics Sales (Tons) by Application (2021–2026)

Table 63. Global Sevoflurane and Desflurane Anaesthetics Sales (Tons) by Application (2027–2032)

Table 64. Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Application (2021–2026)

Table 65. Global Sevoflurane and Desflurane Anaesthetics Sales Market Share by Application (2027–2032)

Table 66. Global Sevoflurane and Desflurane Anaesthetics Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Sevoflurane and Desflurane Anaesthetics Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Application (2021–2026)

Table 69. Global Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Application (2027–2032)

Table 70. Global Sevoflurane and Desflurane Anaesthetics Price (US$/kg) by Application (2021–2026)

Table 71. Global Sevoflurane and Desflurane Anaesthetics Price (US$/kg) by Application (2027–2032)

Table 72. Baxter Company Information

Table 73. Baxter Description and Business Overview

Table 74. Baxter Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 75. Baxter Sevoflurane and Desflurane Anaesthetics Product

Table 76. Baxter Recent Developments/Updates

Table 77. AbbVie Company Information

Table 78. AbbVie Description and Business Overview

Table 79. AbbVie Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 80. AbbVie Sevoflurane and Desflurane Anaesthetics Product

Table 81. AbbVie Recent Developments/Updates

Table 82. Piramal Critical Care Company Information

Table 83. Piramal Critical Care Description and Business Overview

Table 84. Piramal Critical Care Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 85. Piramal Critical Care Sevoflurane and Desflurane Anaesthetics Product

Table 86. Piramal Critical Care Recent Developments/Updates

Table 87. Fresenius Kabi Company Information

Table 88. Fresenius Kabi Description and Business Overview

Table 89. Fresenius Kabi Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 90. Fresenius Kabi Sevoflurane and Desflurane Anaesthetics Product

Table 91. Fresenius Kabi Recent Developments/Updates

Table 92. Halocarbon Company Information

Table 93. Halocarbon Description and Business Overview

Table 94. Halocarbon Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 95. Halocarbon Sevoflurane and Desflurane Anaesthetics Product

Table 96. Halocarbon Recent Developments/Updates

Table 97. Aspen Company Information

Table 98. Aspen Description and Business Overview

Table 99. Aspen Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 100. Aspen Sevoflurane and Desflurane Anaesthetics Product

Table 101. Aspen Recent Developments/Updates

Table 102. Pfizer Company Information

Table 103. Pfizer Description and Business Overview

Table 104. Pfizer Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 105. Pfizer Sevoflurane and Desflurane Anaesthetics Product

Table 106. Pfizer Recent Developments/Updates

Table 107. Maruishi Pharmaceutical Company Information

Table 108. Maruishi Pharmaceutical Description and Business Overview

Table 109. Maruishi Pharmaceutical Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 110. Maruishi Pharmaceutical Sevoflurane and Desflurane Anaesthetics Product

Table 111. Maruishi Pharmaceutical Recent Developments/Updates

Table 112. Jiangsu Hengrui Medicine Company Information

Table 113. Jiangsu Hengrui Medicine Description and Business Overview

Table 114. Jiangsu Hengrui Medicine Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 115. Jiangsu Hengrui Medicine Sevoflurane and Desflurane Anaesthetics Product

Table 116. Jiangsu Hengrui Medicine Recent Developments/Updates

Table 117. Lunan Pharmaceutical Company Information

Table 118. Lunan Pharmaceutical Description and Business Overview

Table 119. Lunan Pharmaceutical Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 120. Lunan Pharmaceutical Sevoflurane and Desflurane Anaesthetics Product

Table 121. Lunan Pharmaceutical Recent Developments/Updates

Table 122. Hikma Pharmaceuticals Company Information

Table 123. Hikma Pharmaceuticals Description and Business Overview

Table 124. Hikma Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 125. Hikma Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Product

Table 126. Hikma Pharmaceuticals Recent Developments/Updates

Table 127. HeBei YiPin Pharmaceutical Company Information

Table 128. HeBei YiPin Pharmaceutical Description and Business Overview

Table 129. HeBei YiPin Pharmaceutical Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 130. HeBei YiPin Pharmaceutical Sevoflurane and Desflurane Anaesthetics Product

Table 131. HeBei YiPin Pharmaceutical Recent Developments/Updates

Table 132. Dechra Pharmaceuticals Company Information

Table 133. Dechra Pharmaceuticals Description and Business Overview

Table 134. Dechra Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 135. Dechra Pharmaceuticals Sevoflurane and Desflurane Anaesthetics Product

Table 136. Dechra Pharmaceuticals Recent Developments/Updates

Table 137. Life Sciences Company Information

Table 138. Life Sciences Description and Business Overview

Table 139. Life Sciences Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 140. Life Sciences Sevoflurane and Desflurane Anaesthetics Product

Table 141. Life Sciences Recent Developments/Updates

Table 142. Zhejiang AngLiKang Pharmaceutical Company Information

Table 143. Zhejiang AngLiKang Pharmaceutical Description and Business Overview

Table 144. Zhejiang AngLiKang Pharmaceutical Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 145. Zhejiang AngLiKang Pharmaceutical Sevoflurane and Desflurane Anaesthetics Product

Table 146. Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates

Table 147. Linde Healthcare Company Information

Table 148. Linde Healthcare Description and Business Overview

Table 149. Linde Healthcare Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 150. Linde Healthcare Sevoflurane and Desflurane Anaesthetics Product

Table 151. Linde Healthcare Recent Developments/Updates

Table 152. Air Liquide Company Information

Table 153. Air Liquide Description and Business Overview

Table 154. Air Liquide Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 155. Air Liquide Sevoflurane and Desflurane Anaesthetics Product

Table 156. Air Liquide Recent Developments/Updates

Table 157. Messer Company Information

Table 158. Messer Description and Business Overview

Table 159. Messer Sevoflurane and Desflurane Anaesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 160. Messer Sevoflurane and Desflurane Anaesthetics Product

Table 161. Messer Recent Developments/Updates

Table 162. Key Raw Materials Lists

Table 163. Raw Materials Key Suppliers Lists

Table 164. Sevoflurane and Desflurane Anaesthetics Distributors List

Table 165. Sevoflurane and Desflurane Anaesthetics Customers List

Table 166. Sevoflurane and Desflurane Anaesthetics Market Trends

Table 167. Sevoflurane and Desflurane Anaesthetics Market Drivers

Table 168. Sevoflurane and Desflurane Anaesthetics Market Challenges

Table 169. Sevoflurane and Desflurane Anaesthetics Market Restraints

Table 170. Research Programs/Design for This Report

Table 171. Key Data Information from Secondary Sources

Table 172. Key Data Information from Primary Sources

Table 173. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sevoflurane and Desflurane Anaesthetics

Figure 2. Global Sevoflurane and Desflurane Anaesthetics Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Sevoflurane and Desflurane Anaesthetics Market Share by Type: 2025 & 2032

Figure 4. Sevoflurane Product Picture

Figure 5. Desflurane Product Picture

Figure 6. Global Sevoflurane and Desflurane Anaesthetics Market Value by MAC (US$ Million), 2021–2032

Figure 7. Global Sevoflurane and Desflurane Anaesthetics Market Share by MAC: 2025 vs 2032

Figure 8. Below 3% Product Picture

Figure 9. Above 3% Product Picture

Figure 10. Global Sevoflurane and Desflurane Anaesthetics Market Value by Airway Tolerability (US$ Million), 2021–2032

Figure 11. Global Sevoflurane and Desflurane Anaesthetics Market Share by Airway Tolerability: 2025 vs 2032

Figure 12. Less Pungent Product Picture

Figure 13. More Pungent Product Picture

Figure 14. Global Sevoflurane and Desflurane Anaesthetics Market Value by Application (US$ Million), 2021–2032

Figure 15. Global Sevoflurane and Desflurane Anaesthetics Market Share by Application: 2025 & 2032

Figure 16. Human Use

Figure 17. Animal Use

Figure 18. Global Sevoflurane and Desflurane Anaesthetics Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Sevoflurane and Desflurane Anaesthetics Market Size (US$ Million), 2021–2032

Figure 20. Global Sevoflurane and Desflurane Anaesthetics Sales (Tons), 2021–2032

Figure 21. Global Sevoflurane and Desflurane Anaesthetics Average Price (US$/kg), 2021–2032

Figure 22. Sevoflurane and Desflurane Anaesthetics Report Years Considered

Figure 23. Sevoflurane and Desflurane Anaesthetics Sales Share by Manufacturers in 2025

Figure 24. Global Sevoflurane and Desflurane Anaesthetics Revenue Share by Manufacturers in 2025

Figure 25. Top 5 and Top 10 Global Sevoflurane and Desflurane Anaesthetics Players: Market Share by Revenue in Sevoflurane and Desflurane Anaesthetics in 2025

Figure 26. Sevoflurane and Desflurane Anaesthetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 27. Global Sevoflurane and Desflurane Anaesthetics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 28. North America Sevoflurane and Desflurane Anaesthetics Sales Market Share by Country (2021–2032)

Figure 29. North America Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Country (2021–2032)

Figure 30. United States Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Canada Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Europe Sevoflurane and Desflurane Anaesthetics Sales Market Share by Country (2021–2032)

Figure 33. Europe Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Country (2021–2032)

Figure 34. Germany Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. France Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. U.K. Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Italy Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Russia Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Asia Pacific Sevoflurane and Desflurane Anaesthetics Sales Market Share by Region (2021–2032)

Figure 40. Asia Pacific Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Region (2021–2032)

Figure 41. China Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Japan Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. South Korea Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. India Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Australia Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. China Taiwan Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Indonesia Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Thailand Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Malaysia Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Latin America Sevoflurane and Desflurane Anaesthetics Sales Market Share by Country (2021–2032)

Figure 51. Latin America Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Country (2021–2032)

Figure 52. Mexico Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Brazil Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Argentina Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Middle East and Africa Sevoflurane and Desflurane Anaesthetics Sales Market Share by Country (2021–2032)

Figure 56. Middle East and Africa Sevoflurane and Desflurane Anaesthetics Revenue Market Share by Country (2021–2032)

Figure 57. Turkey Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Saudi Arabia Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. UAE Sevoflurane and Desflurane Anaesthetics Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Global Sales Market Share of Sevoflurane and Desflurane Anaesthetics by Type (2021–2032)

Figure 61. Global Revenue Market Share of Sevoflurane and Desflurane Anaesthetics by Type (2021–2032)

Figure 62. Global Sevoflurane and Desflurane Anaesthetics Price (US$/kg) by Type (2021–2032)

Figure 63. Global Sales Market Share of Sevoflurane and Desflurane Anaesthetics by Application (2021–2032)

Figure 64. Global Revenue Market Share of Sevoflurane and Desflurane Anaesthetics by Application (2021–2032)

Figure 65. Global Sevoflurane and Desflurane Anaesthetics Price (US$/kg) by Application (2021–2032)

Figure 66. Sevoflurane and Desflurane Anaesthetics Value Chain

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Medical Sevofluran Market Research Report 2025

Global Fluorine Anesthetic Market Research Report 2024

Global Halothane Market Research Report 2025

Global Inhalation Anesthetic Market Research Report 2024

Global Anesthetics Market Insights Forecast to 2030

Global Anaesthesia Machines Market Research Report 2024

General Anaesthetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global General Anaesthesia Drugs Market Research Report 2024

Global Nitrous Oxide Sedation System Market Research Report 2025

Global Nitrous Oxide Sedation Machine Market Research Report 2025

Global Sevoflurane Anesthesia Vaporizers Market Research Report 2024

Global Sevoflurane and Isoflurane Anesthesia Vaporizers Market Research Report 2024

Global Isoflurane Anesthesia Vaporizers Market Research Report 2024

Global Sevoflurane Source Market Insights Forecast to 2030

Global Inhalational Anaesthesia Drugs Market Research Report 2024

Anaesthetic and Respiratory Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anaesthetic Syringe Market Research Report 2025

General Anesthesia Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Desflurane Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions